HomeIngredientSeasonal changes in rosemary species: A chemotaxonomic assessment of two varieties based on essential oil compounds, antioxidant and antibacterial activities

Seasonal changes in rosemary species: A chemotaxonomic assessment of two varieties based on essential oil compounds, antioxidant and antibacterial activities

October 23, 2022

PLoS One. 2022 Aug 29;17(8):e0273367. doi: 10.1371/journal.pone.0273367. eCollection 2022.

ABSTRACT

Rosemary (Rosmarinus officinalis L.) is a popular herb in cooking, traditional healing, and aromatherapy. This study was conducted to evaluate the effects of meteorological conditions plant growth stage and genetic factors on the yield, quantitative and qualitative composition, on the antioxidant and antimicrobial activities of rosemary essential oil from two Tunisian locations (El Fahs and Matmata) during two successive years. The composition of the essential oils obtained by hydrodistilation from rosemary plants were carried out annually using GC and GC/MS. Results showed the the main constituents were camphor (18.2-28.1%), 1,8-cineole (6.4-18.0%), α-pinene (9.7-13.5%), borneol (4.4-9.5%), and camphene (5.1-8.7%). The principal component and heatmapper analyses showed group segregation of the two studied varities based on major essential oil compounds. Additionally, in vitro antimicrobial and antioxidant activities showed that rosemary essential oils had an important ability in scavenging DPPH, as well as a higher bactericidal effect. The seasonal variation, growth stage and genetic pools seemed to be a factors of significant variation of the composition, antimicrobial and the antioxidant activities of the rosemary essential oils. These finding would be taken to use the chemotaxonomy tools to develop a program for Rosmary protection conservation and identification based on essential oil composition.

PMID:36037220 | DOI:10.1371/journal.pone.0273367

Tags:,

Related Posts

About The Author

Patrick Blanchard MD

Meet Dr. Blanchard Dr. Blanchard’s medical practice is an embodiment of Integrative health which brings conventional and complementary approaches together in a coordinated way. Conveniently located in sunny Florida and over the internet with ValiseMD’s secure HIPPA compliant telXmed servers. Since 1994, patients with a wide range of challenging medical problems have achieved optimum health using the best of natural medicine, judiciously combined with high-tech innovations. Breakthroughs are often achieved even after patients have consulted mainstream specialists and holistic practitioners. Dr. Blanchard is founder and CEO of ValiseMD, Inc. He is board certified in Family Medicine since 1994 and awarded Fellow of the American Academy of Family Physicians in 2001. He received the ‘Teacher of the Year’ award from the University of Kansas School of Medicine at completion of his residency in Family Medicine. He completed a fellowship at Wake Forest University in the field of vascular neurosonology. He holds a medical patent in the field of Gastroenterology. He holds an unrestricted license to practice medicine and surgery in Florida. He started his medical career as a Emergency Medical Technician, then as a Paramedic and later a Medical Doctor.